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            Bowel Pattern in General Population and in Irritable Bowel 
Syndrome           
INTRODUCTION
Normal bowel habits vary considerably from person to person. Anything from 3 times a day to 3 times 
a week can be quite normal.  The colon and rectum plays an important role in regulating the bowel frequency, 
its movement and in maintaining its consistency.
Normal Physiology
The colon receives approximately 1.5 liters of fluid each day.  The normal fluid volume of stool is 
about  100 ml.  The  ascending  and  transverse  colon  serves  as  a  site  for  storage  and fluid  and electrolyte 
absorption. The descending and sigmoid colon functions as a conduit. Faeces empty rapidly from the cecum 
and ascending colon and are retained for several hours in the transverse colon. The descending colon propels 
material into the rectum, where it is stored prior to defecation.   Following a meal and after awakening, high 
amplitude contractions propagate from the proximal to distal sigmoid colon, pushing the stool mass into the 
rectum. Normal transit from the cecum to the rectum using radio opaque markers varies from 24 to 100 hours 
in different population 
Normal  defecation  is  controlled  by  the  pelvic  complex,  a  funnel  consisting  of  two  overlapping 
sphincters surrounding the anus: an internal sphincter composed of involuntary smooth muscle and an external 
sphincter composed of voluntary skeletal muscle that maintains continence. When the rectum is empty, the 
internal sphincter muscle is tonically contracted and the external sphincter relaxed. When stool is propelled 
into  the  rectum,  stretch  receptors  in  the  walls  are  stimulated.  These  receptors  activate  nerve  cells  in  the 
intramural plexus. In turn, inhibitory interneurons decrease the activity of the muscles of the internal anal 
sphincter, causing it to relax. Following internal sphincter relaxation, stool comes in contact with the very 
sensitive anoderm lining of the external anal canal. This leads to an urge to defecate. If convenient, toileting 
proceeds by assuming a squatting position, which straightens the anal canal, and then a Valsalva maneuver is 
performed  which  increases  intraabdominal  pressure,  and  defecation  proceeds,  evacuating  the  rectum. 
Alternatively, the external anal sphincter and gluteal muscles can be contracted voluntarily, ejecting the fecal 
mass out of the rectal ampulla back into the rectal vault. The urge to defecate subsides until the rectum again 
becomes distended (Fig 1 & 2).
 
 
                                              Figure 2: Mechanism of defecation.
Functional bowel disorders  
These are disorders that can affect the entire digestive tract from the mouth to the anus. A functional bowel 
disorder (FBD) is a functional gastrointestinal disorder with symptoms attributable to the mid or lower 
gastro-intestinal tract, without significant infectious, metabolic or anatomical abnormalities. These include 
the irritable bowel syndrome (IBS), functional constipation, functional diarrhoea and functional abdominal 
bloating.
1. Irritable  Bowel  Syndrome:  This comprises  of  a  group  of  functional  bowel  disorders  in  which 
abdominal discomfort or pain is associated with defecation or a change in the bowel habit, and with 
features of disordered defecation. The cause of IBS is unknown. Emotional factors, diet,  drugs, or 
hormones may precipitate or aggravate heightened GI motility.
       Figure 3. Multicomponent Model of Irritable Bowel Syndrome
Multicomponent  model  of  irritable  bowel  syndrome  (IBS): Development  of  IBS  symptoms  can  be 
explained by the interrelation of cognitive, behavior, emotional, and physiologic components (Fig. 3).
In  IBS,  the  circular  and  longitudinal  muscles  of  the  small  bowel  and  sigmoid  are  particularly 
susceptible  to  motor  abnormalities.  The  proximal  small  bowel  appears  to  be  hyper-reactive  to  food  or 
parasympathomimetic drugs. Small bowel transit is variable in patients with IBS, and changes in bowel transit 
time often do not correlate with symptoms. Intra luminal pressure studies of the sigmoid colon show that 
functional  constipation  can  occur  when  haustral  segmentation  becomes  hyper-reactive  (i.e.  increased 
frequency and amplitude of contractions); in contrast, diarrhoea is associated with diminished motor function. 
Excess mucus production, which often occurs in IBS, is not related to mucosal injury. Its cause is unclear, but 
it may be related to cholinergic hyperactivity.
Hypersensitivity to normal amounts of intra-luminal distention exists, as does a heightened perception 
of pain in the presence of normal quantity and quality of intestinal gas. The pain of IBS seems to be caused by 
abnormally strong contraction of the intestinal smooth muscle or by increased sensitivity of the intestine to 
distention.  Hypersensitivity  to  the  hormones  gastrin  and  cholecystokinin  may  also  be  present.  However, 
hormonal fluctuations do not correlate with clinical symptoms. The caloric density of food intake may increase 
the magnitude and frequency of myoelectrical activity and gastric motility. Fat ingestion may cause a delayed 
peak of motor activity,  which can be exaggerated in IBS. The first few days of menstruation can lead to 
transiently elevated prostaglandin E2, resulting in increased pain and diarrhoea and is not caused by estrogen 
or progesterone. 
IBS tends to begin in the second and third decades of life, causing bouts of symptoms that recur at 
irregular periods. Onset in late adult  life is rare.  Symptoms usually occur in a wakeful patient and rarely 
manifests in a sleeping patient. Symptoms can be triggered by stress or the ingestion of food. Two major 
clinical types of IBS have been described-Constipation-Predominant IBS and Diarrhoea-Predominant IBS .The 
other rare pattern is alternating diarrhoea and constipation type. 
Diarrhoea predominant IBS: Usual frequency of stool is more than three times per day, or usual form of 
stool is loose and not hard, or subjects frequently feel a sense of urgency but do not feel the need to strain to 
defecate.
Constipation predominant IBS: Usual frequency of stool is less than three times per week, or usual form of 
stool is hard and not loose, or subjects frequently feel a sense of need to strain to defecate but do not feel the 
sense of urgency.
Non-specific  IBS:  These include individuals who do not fulfill  the previous 2 categories:  i.e.  criteria  for 
Diarrhoea Predominant or Constipation Predominant IBS. 
Figure 4. Pathophysiology and therapeutic strategies.
.2. Functional  constipation comprises  a  group  of  functional  disorders,  which  presents  as  persistent 
difficult,  infrequent  or  seemingly  incomplete  defecation.  There  is  an  overlap  between  IBS  - 
Constipation type and functional constipation. The pain component, which is predominant in IBS, is 
absent here.
3. Functional diarrhoea is continuous or recurrent passage of loose (mushy) or watery 
stools without abdominal pain.  There is  once again an overlap between IBS -  Diarrhoea type and 
functional Diarrhoea. 
Functional  bowel  disorders are  common in the West.  Data  on the normal  bowel  habit  and prevalence of 
functional bowel disorders amongst the population of the Indian subcontinent is limited.
 
Literature  review
Epidemiology
Normal bowel habits vary considerably from person to person. There are very reports on the normal 
bowel frequency from India; population based studies are fewer.  Most of the studies are from west. In study 
by Abraham et al 1 from Mumbai, based on a questionnaire survey conducted among the patient’s relatives, the 
normal median bowel frequency in healthy Indian adults was 2 per day. In another study from southern part of 
Tamilnadu in the city of Coimbatore, the average bowel frequency was once a day.2 
Prevalence
United States   
Several criteria have been designed to define IBS.  Depending on the criteria used, worldwide, IBS has 
been reported in 17-22% of the healthy population, 3-5 chronic constipation in 3-17% 5,6and chronic diarrhoea in 
2-18%.5,6 A population-based prevalence in USA estimates IBS prevalence to range from 10% to 15%. 5,6 
Approximately 12% of these patients are seen in the primary care setting and in 28% of patients seeking 
subspecialty gastroenterology care.6 Although IBS affects both sexes, it is largely considered a women's health 
issue. Epidemiological data 3,7 suggests that the female : male ratio of IBS sufferers in the community is 2-3:1, 
although  estimates  differ  depending  on  the  practice  setting  from which  such  assessments  are  generated. 
Generally, two thirds of IBS sufferers in North America who seek medical care are women.  5 Although the 
minority (25%) of individuals with typical symptoms of the disorder actually does seek medical care, the high 
prevalence of IBS translates into a sizeable absolute number of patients.5 Recent reports estimate,  physician 
visits  attributable to IBS to be as high as 3.5 million visits annually.  Additionally,  it  has been repeatedly 
demonstrated that  patients  with IBS are  more likely to  seek medical  care  for  other  non-GI conditions or 
physical complaints, such as fibromyalgia or chronic pelvic pain. Bowel frequency was more amongst whites 
than nonwhites (7.8 vs. 6.0 stools per week, p< 0.0001);  men reported more frequent stools than women (9.2 
vs. 6.7 stools per week, p< 0.0001). 8
To  examine  the  prevalence  of  gastrointestinal  symptoms,  Tutega  and  colleagues9 reviewed  1069 
employees of an integrated healthcare system in Salt Lake City, Utah, 623 of whom responded to a validated 
questionnaire. They found a striking overlap between IBS and functional dyspepsia: 70% of individuals with 
IBS also had functional dyspepsia, whereas 43% of subjects with dyspepsia also had IBS. Individuals with 
overlap consulted a physician more frequently than those who had IBS or dyspepsia alone.9
In a community survey from Olmsted County, Minnesota, Locke and colleagues10 evaluated a similar 
number  of  subjects  drawn from the  general  population.  Six  hundred  fifty-seven  of  935  eligible  subjects 
responded to a validated questionnaire. The authors of this study found that symptom complex overlap was 
much more the rule than the exception in this community sample. This applied to IBS with constipation as well 
as IBS with diarrhoea in terms of an overlap with upper gastrointestinal tract symptoms. It was important to 
note  that  there  was  no  predominant  pattern  of  overlap  identified  consistent  with  a  common  underlying 
pathophysiology.  Hence,  artificial  subdivision  of  these  functional  gastrointestinal  complaints  may  not  be 
particularly helpful in terms of patient management. 10
European countries 
In a Spanish study by Roig Vila et al11 among a working population, the average number of stools was 7.1 + 3.3 per week 
and in 62.4% of subjects the range was 5 and 8. Bowel movements were less frequent in women than in men, nevertheless there were 
no differences with regard to the age. Laxatives were used regularly by 11.3%.  36% referred straining at stool at least 25% of the 
times and 8.3% referred straining even for loose stools. Alternating bowel function was present in 19.4% and functional abdominal 
pain in 28% with a female predominance. 
Bassotti et al  12  noted a similar bowel frequency between males and females. The average defecatory 
frequency was once per day (range of 0.25-3.25). A higher frequency of straining at stool (P=0.001), a feeling 
of  incomplete  emptying  and  /  or  difficult  evacuation  (P=0.0001),  and  manual  maneuvers  to  facilitate 
defecation (P=0.046) were reported by females as compared to males.
Zuckerman et al 7 studied the functional bowel disorder pattern among healthy population of whites and 
Hispanics and found that the frequency of IBS-type symptoms was greater in females than in males. Females 
reported more alternating bowel pattern (44.0% vs. 28.5%, P < 0.001) and constipation (25.5% vs. 12.4%, P < 
0.01) than males. 
 
South Asian countries 
Similar data on the prevalence of functional bowel disorders in Asia are limited. Two studies – one 
from Thailand and the other from Singapore reported the prevalence of IBS to be lower than those reported in 
the West 13,14 
In the study from Singapore, 14 the prevalence of IBS, chronic constipation and chronic diarrhoea were 
3.2 + 2.3%, 7.3 + 3.5% and 6.9 + 3.4%, respectively.  Women were found to have a lower bowel frequency 
(p<0.001) and a higher prevalence of chronic constipation (11.3 + 6.0% vs. 3.6 + 3.5%, p<0.05) than men. The 
prevalence of IBS in the general population of Singapore was low compared with those reported in the West In 
Japan, the normal and diarrhoea responses were significantly more common in men and constipation response 
was significantly more common in female. 15
Table 1.Irritabe bowel syndrome : Prevalence studies in Asia
Author Setting N Survey method IBS definition Prevalence
Gwee16 Singapore 2276 Face to face interview Manning
Rome1
Rome 2
11
10.4
8.6
Xiong17
Lau18
Kwan19
Danivat13
Masud20
Rajendra21
Pan22
Ho23
South China
Hong Kong
Hong Kong
Thailand
Bangladesh
Malaysia
China
Singapore
4178
1298
1797
1077
2476
949
2486
696
Face to face interview
Face to face interview
Phone interview
Questionnaire
Face to face interview
Face to face interview
Questionnaire
Face to face interview
Manning
Rome2
Rome2
Rome2
Manning
Rome1
Rome2
Manning
Rome1
Manning
11.5
5.6
3.7
6.6
4.4
8.5
14
7.3
0.8
2.6
Diet and IBS
Saito and colleagues 24 presented their findings from a case-control study conducted in Olmsted County 
comparing  dietary  consumption  of  specific  nutrients  in  subjects  who  had  a  presumed  functional 
gastrointestinal disorder with controls (i.e. those without symptoms). A validated food frequency questionnaire 
was applied. Patients with functional gastrointestinal symptoms consumed a higher percentage of fat, but there 
were  no  other  major  differences  observed  between  the  2  groups,  although  there  was  a  modestly  lower 
percentage of carbohydrate, vitamin C, and sugar consumed by individuals with functional gastrointestinal 
complaints. 
 
In a study to find out the absolute fiber intake from different sources of food items in patients with IBS 
and healthy subjects Malhotra et al 25 from Chandigarh, India found that the total dietary fiber intake and intake 
of fiber from vegetables, fruits and pulses were lower in patients with IBS than in control subjects. 
Because there are no discrete physical abnormalities or biochemical/serological markers that define IBS, this condition has 
historically been viewed by many clinicians as a diagnosis of exclusion. This view, coupled with the increasing number and cost of 
available diagnostic studies, has resulted in extensive and unnecessary testing. An exhaustive exclusionary diagnostic evaluation, 
especially in patients with typical IBS symptoms without alarm features (age ≥ 50 years, fever, abnormal physical examination 
findings, haematochezia, unintentional weight loss, nocturnal symptoms, or a family history of organic GI disease), contributes to an 
increased  burden  on  both  patients  and  the  medical  system,  and  recently  has  been  challenged  regarding  its  usefulness  in  the 
management of such patients.26
Diagnosis
 The economic burden associated with IBS, both direct and indirect, is substantially high with frequent 
physician visit, absenteeism from work, decreased work output. To mitigate some of the costs associated with 
IBS,  accurate  and  timely  diagnosis  is  an  important  consideration.  For  IBS,  applying  clinically  proven 
symptom-based diagnostic criteria to make a positive, rather than exclusionary, diagnosis is an important step 
in the right direction to reduce the overall cost. 
A diagnosis  of  IBS is  based  on  identifying  positive  symptoms  consistent  with  the  condition,  and 
excluding, in a cost-effective manner other conditions with similar clinical presentations, which may include 
organic  or  other  functional  (e.g.,  functional  diarrhoea  or  bloating,  pelvic  floor  disorders,  or  slow transit 
constipation with associated abdominal discomfort relieved with defecation) disorders. 
Multiple symptom-based criteria have been developed: Manning, Kruis, Rome, Rome I   and Rome II 
criteria. 
Symptom-based criteria 27
Manning criteria for diagnosis of IBS
1. Abdominal pain relieved by defecation
2. Looser stools with the onset of pain
3. More frequent stools with the onset of pain
4. Abdominal distention 
5. Passage of mucus in stools
6. Sensation of incomplete evacuation
Rome I Diagnostic Criteria for Irritable Bowel Syndrome
At least 3 months of continuous or recurrent symptoms of the following:
• Abdominal pain or discomfort 
• Relieved with defecation, or 
• Associated with a change in frequency of stool, or 
• Associated with a change in consistency of stool 
Two or more of the following, at least on one-fourth of occasions or days: 
• Altered stool   frequency   (for  research  purposes altered  may  be defined  as  more  
• than   three  bowel movements  each  day or  less  than  three bowel  movements          each week), or 
• Altered stool form (lumpy/hard or loose/watery stool), or 
• Altered stool passage (straining, urgency, or feeling of incomplete evacuation), or 
• Passage of mucus, or
• Bloating or feeling of abdominal distention
Rome II criteria
At least 12 weeks, which need not be consecutive, in the preceding 12 months of abdominal discomfort or pain 
that has 2 of 3 features:
• Relieved with defecation; and/or
• Onset associated with a change in frequency of stool; and/or
• Onset associated with a change in form (appearance) of stool.
Symptoms that cumulatively support the diagnosis of IBS:
• Abnormal stool frequency (for research purposes, ‘abnormal’ may be defined as greater than three 
bowel movements per day and less than 3 bowel movements per week);
• Abnormal stool form (lumpy/hard or loose/watery stool);
• Abnormal stool passage (straining, urgency, or feeling of incomplete evacuation);
• Passage of mucus;
• Bloating or feeling of abdominal distention.
Among  the  commonly  symptom  based  criteria,  Manning  criteria  has  been  the  most  extensively 
evaluated and it is the only diagnostic criteria that has been evaluated in clinical studies. 28 Manning criteria has 
a positive predictive value of only 65-75%. 29
The primary reason why Rome criteria was introduced was to provide a uniform. framework for selecting patients with 
functional GI disorders for clinical research. In recent years the extension of the Rome criteria to routine clinical practice has been 
encouraged. 30 Rome II criteria have the advantage of being easier to recall than the older Manning or Roman criteria. When “alarm 
features” such as weight loss, refractory diarrhoea, and family history of colon cancer are excluded, the specificity of the symptom-
based Rome I criteria for IBS exceeds 98% and hence, the risk of missing organic disease is low. 31  In a recent study from South 
India among IBF patients Banerjee et al49 showed that ROME I criteria are more sensitive than ROME II for diagnosis of irritable 
bowel syndrome in Indian patients.  
Evaluation
A detailed physical examination is essential on the first and on subsequent visits as needed. Review of the case during 
subsequent  visits  is  essential  so  as  to  avoid  missing  an  organic  disease  e.g.  enlarged  liver,  abdominal  mass,  signs  of  bowel 
obstruction.   Also  this  would  envisage  patient's  expectations  of  a  thorough clinical  evaluation.  A pelvic  examination  is  often 
indicated for lower abdominal / pelvic symptoms and/or if there is a change in menstrual pattern. A rectal examination, particularly 
for patients reporting symptoms of incontinence or dyschezia, can help to identify a lax sphincter or paradoxical pelvic floor muscle 
contraction. This may require anorectal testing of pelvic floor muscle function.
In general, if Rome criteria are fulfilled, “alarm signs” or “red flags” are not present, and screening studies from the referring 
physician are negative,  further testing is not needed. Screening studies are recommended when certain historical information is 
present 32
(1) Short symptom duration or worsening severity and  refractory  symptoms, 
(2) Demographic features (e.g., onset in an older patient), 
(3) Family history (e.g., colon cancer or inflammatory bowel disease), and 
(4) No concurrent psychosocial difficulties or symptom behavior (particularly the absence of co morbid psychosocial features 
or health care seeking).
 Tolliver et al  33 examined the use of faecal occult blood testing (FOBT) in patients with suspected IBS. Fifteen of 183 
patients (8.2%) had a positive FOBT and subsequently underwent full colonoscopic examination. Four of the 15% with positive 
FOBT or 2.2% of the original cohort had structural abnormalities identified in colonoscopy. None of these findings were felt to 
represent an alternative diagnosis nor were these findings felt to provide an explanation for the patients IBS symptoms. 33
Examination of stool for ova and parasite is another commonly recommended test for patients with suspected IBS. Hamm 34 
found that 1.7% of patients with suspected IBS had an evidence of intestinal pathogen on standard stool O & P examination. Tolliver 
33 performed stool O&P examination in 170 patients with suspected IBS and found no subjects with evidence of enteric infection. 
AGA (American Gastroenterology Association) recommends 35 a complete blood count and a stool hemoccult for screening 
purposes. Sedimentation rate (particularly in a younger patient), serum chemistries, thyroid-stimulating hormone (TSH), and stool 
for ova and parasites are other baseline investigations and are tailored based on symptom pattern, geographic area, and relevant 
clinical features (e.g., predominant diarrhoea, areas of endemic infection).
 In a trial by Tolliver36 et al CBC and serum chemistries were performed in 196 patients in suspected IBS. In this trial the 
results failed to result in an alternative diagnosis of organic GI disease in any patient. Studies do not generally support a role for 
these tests without supportive clinical features. 37
  Prevalence of lactose malabsorption is estimated to be 25% in western countries and perhaps as high as 75% worldwide. 
In the study by Tolliver  33, 186 patients with suspected IBS had hydrogen breath test. The author found a similar prevalence of 
lactose malabsorption with 25.8% (48 out of 186) of the cohort having abnormal results. On follow-up these patients with lactose 
malabsorption did not differ with respect to the ongoing GI symptoms when compared with patients without evidence of lactose 
malabsorption. 33 The clinical impact of identifying lactose intolerance in IBS patients remains unclear.
Francis et al 38 evaluated the role of ultrasound (US) to identify serious abdominal or pelvic pathology in 125 patients with 
suspected IBS and found 20% of women and 8% of men had some abnormality in US. But in none of them were the authors able to 
correlate  the  abnormalities  identified  on US to  the  patient  with  GI symptoms.  They concluded  that  US was  not  necessary in 
suspected IBS when diagnosed by symptom criteria.
 Few studies have evaluated the yield of endoscopic investigations in suspected IBS. Hamm 37  examined 306 patients and 
found four patients (1.3%) had an alternative diagnosis (IBD in 3 patients, colonic obstruction in one) that might have been the cause 
for the GI symptoms.  Tolliver  33  performed similar analysis in 199 patients and found 42 colonic structural abnormalities in 34 
subjects. Of these only 2 patients (1%) were found to have an organic disease (IBD-1, Cancer-1) that could have been potential  
causes of IBS symptoms. A colonoscopy is recommended for patients over the age of 50: at least in the West (due to higher pretest 
probability of colon cancer), but in younger patients, performing a colonoscopy or sigmoidoscopy is determined by clinical features 
suggestive of disease (e.g., if there is significant diarrhoea) and may not always be indicated.
Table 2. Pretest probability of organic gastrointestinal disease in patients meeting symptom-based criteria for IBS. 39
Organic GI disease
IBS patients
(pretest probability)
General population
(prevalence)
Colitis/IBD
Colorectal cancer
Gastrointestinal infection
Thyroid dysfunction
Lactose malabsorption
0.51-0.98%
0-0.51%
0-1.7%
6%
22-26%
0.3-1.2%
4-6%
N/A
5-9%
25%
 There has been growing interest in the use of antiendomysial (EMA) and antigliadin (AGA) antibodies to diagnose celiac 
sprue.40,41   Using  decision  analytical  modeling  Mein  et  al  42  concluded  testing  patients  with  suspected  IBS  with  either  tissue 
transglutaminase antibodies (TTg) or antibody panel  (TTg, AGA, IGA) was highly cost effective. In  a sensitivity analysis TTg 
testing remained cost effective in patients with suspected IBS as long the prevalence was >1.1%. However, such testing must be put 
into a clinical perspective as determined by presence of symptom pattern, ethnicity, and other clinical features suggestive of the 
disease and most importantly prevalence of the disease in that particular region. 41 
In many situations, a therapeutic trial can be undertaken before further diagnostic studies are done and this would depend on 
the symptom subtype and its severity.  For constipation: a trial with dietary fiber, or an osmotic laxative; for diarrhoea: loperamide, 
or  diphenoxylate-atropine  and  possibly  cholestyramine;  and  for  pain/gas/bloating:  an  anticholinergic,  or,  if  more  severe, 
antidepressant or psychologic treatment may be considered. It needs to be emphasized that patients presenting with typical symptoms 
and  no  “alarm” signs  are  rarely found  to  have  another  diagnosis, 37 supporting the  benefit  of  ongoing  care  and  symptomatic 
management rather than continued diagnostic evaluation.
If  initial  treatment  fails,  or  certain  clinical  features  emerge  requiring  further  evaluation,  AGA  recommend  further 
evaluation. Gastroenterologists in specialty centers perform several of these studies.
In patients with infrequent bowel movements, whole gut transit study by Sitzmark technique or a plain radiography (to 
evaluate for obstructive signs or fecal retention) is indicated. When symptoms of dyschezia or incomplete evacuation are prominent, 
suggesting obstruction to defecation, or when the physical examination discloses poor pelvic floor relaxation with straining, further 
anorectal  testing  is  indicated.  This  includes  anorectal  motility  testing  with  balloon  expulsion  (to  evaluate  for  pelvic  floor 
dyssynergia) or defecography (to evaluate for enterocele or rectocele).
If  diarrhoea  is  persistent,  other  tests  to  consider  include:  24-hour  stool  volume  and  fat;  if  increased  (>400  ml/day), 
electrolytes and laxative screen; and small bowel biopsy for  giardia lambia or sprue and colonic biopsy for microscopic colitis is 
recommended. On occasion, transit tests of the small bowel and colon can help evaluate the severity of the motility component of the 
diarrhoea. A therapeutic trial of cholestyramine may also be considered, particularly if symptoms developed or worsened after a 
cholecystectomy. A jejunal biopsy and aspirate can be done to obtain samples to assess malabsorption (e.g., sprue), or to obtain an 
aspirate for giardia or for bacterial overgrowth. Colonic biopsies can be considered to evaluate for collagenous or lymphocytic 
colitis, although the findings may not lead to instituting more effective treatment. Finally, when postprandial symptoms of bloating 
and gaseousness accompany the diarrhoea, a breath H2 study to exclude bacterial overgrowth can be considered. 43
The persistence of pain-predominant symptoms or severe bloating usually requires plain abdominal radiography during an 
acute episode to exclude bowel obstruction, an increased gastric air bubble from aerophagia, and/or other abdominal pathology. If 
negative, additional imaging studies (e.g., small bowel radiography, computerized tomography scan, pelvic ultrasonography) may be 
recommended, particularly when there are other symptoms or signs present (e.g., vomiting, weight loss, abdominal mass, irregular 
menses, abnormal chemistries). A balloon distention test may confirm rectal or colonic visceral hypersensitivity, although this test is 
usually done for investigative purposes.
Figure 5: Algorithm for evaluation of IBS patients BSG proposed guidelines
 
Though plenty of literature  is  available  from the west,  data on normal bowel habit  and pattern of 
functional bowel disorder is scarce from the Indian subcontinent.   An earlier retrospective study from South 
India had refuted the applicability of Rome criteria in patients with IBS.47 (Jayanthi et al)  A prospective study 
is likely to clearly define the applicability or non-applicability of popular ROME criteria. 
                                                                
Aim of the study
1. To define the bowel frequency / habits in the general population of South India and to determine the 
prevalence of Irritable bowel disorder and its subtypes in the population.         
2. To identify prospectively the bowel pattern in irritable bowel syndrome in gastroenterology referral 
practice at a tertiary center.
3. To propose guidelines for diagnosis of IBS in south Indian patients.
MATERIALS AND METHODS
The study was divided into two parts:  
A:  Study of normal bowel pattern in healthy south Indian population
B:  Prospective study of bowel pattern in IBS
A) Study of normal bowel pattern 
           The study group consisted of healthy population belonging to either sex and age between 15 yrs 
and above and less than 70 yrs and who were residents of North Chennai for minimum period of one 
year. Extremes of age were excluded because of possibility of unsettled bowel habits in younger age and 
physiological problems of aging and poor recall in the elderly.  All the individuals were interviewed for 
their perception of bowel movements and the reply was documented in a prestructured questionnaire 
(Annexure I). Details apart from demographic and socio economic characteristics included social habits 
such  as  smoking and drinking  pattern,  bowel  movement  details  such as  the  frequency,  consistency, 
straining during bowel movement and satisfaction of bowel emptying. Any change in the consistency of 
stools or a change in bowel habit in the preceding year, if any, was documented. The stool form was 
determined by showing Bristol stool form scale. (fig.6) Finally, the individuals were questioned whether 
they considered themselves normal or not.  
   B:  Study of bowel pattern in IBS
             Individuals amongst the healthy population in whom the bowel pattern was considered as 
abnormal, and in those who had an alteration in bowel symptoms for a period of more than 3 months 
with or without abdominal pain probably had  an IBS and were considered for further evaluation.  These 
patients  along with cases diagnosed as IBS between Jan 2004 and June 2005 were analysed for the 
pattern  of  bowel  movement.  All  these  patients  with  a  clinical  diagnosis  of  IBS  had  a  detailed 
questionnaire completed (Annexure II).  The data obtained included basic demographic characteristics 
such as social habits:  alcohol, smoking, literacy status, sleep pattern:  normal/disturbed, stress:  at home/
place of work; duration of symptoms and details pertaining to the bowel habits: 
i. Abdominal pain:  location, duration, 
ii. Stool form (Bristol stool scale), frequency 
iii. Relationship of abdominal pain to act of defecation
iv. Incomplete evacuation
v. Presence or absence of mucus in stool
vi. Urgency
Absence of pain was not an exclusion criteria.  Other patient details included ability to cope with 
stress at home or at place of work and sleep pattern :  early morning wakefulness, late onset of sleep, 
symptoms pertaining to the upper GI tract such as ulcer-like, dysmotility like,  reflux like dyspepsia, 
genitourinary symptoms. 
All these patients had a detailed physical examination followed by  basic investigations such as 
blood counts,  blood sugar,  stool microscopy,  thyroid function tests,  duodenal biopsy (rule out small 
bowel cause for diarrhoea) and sigmoidoscopy/colonoscopy based on the department protocol to rule out 
organic diseases. 
The  analysis  was  done  to  obtain  the  prevalence  of  various  symptoms  in  the  diarrhoea 
predominant, constipation predominant and combination type.  
Figure 6. Bristol stool scale.
 Diarrhoea predominant IBS subgroup was defined if the usual  frequency  of   stool     was >3 times per 
day, or the usual form of stool was loose and not hard, or the subjects frequently felt a sense of urgency but did 
not feel the need to strain to defecate
Subjects were classified as constipation predominant IBS subgroup if the usual frequency of the stool 
was<3 times per week, or the usual form of stool was hard and not loose or the subjects frequently felt the 
need to strain to defecate but did not feel the sense of urgency.44
Non-specific IBS subgroup subjects were those who did not fulfill the above criteria for diarrhoea or 
constipation predominant IBS subgroups. 
Exclusion criteria
Individuals with alarm symptoms such as bleeding per rectum, anemia, weight loss, anorexia, 
nocturnal  symptoms,  recent  change  in  bowel  pattern,   post  operative  cases  including  post 
hemorrhoidectomy, fissure in ano, those on antidepressants,  recently detected hypothyroid state, diabetes 
mellitus, or following radiotherapy were excluded from the study.  A minimum duration of change in 
bowel habits of 3 months was considered necessary for inclusion in the study protocol.
             Formal ethics committee approval of the Institution was obtained. Informed consent was 
obtained for the IBS individuals detected from amongst the healthy population for further evaluation.  
Statistical Analysis
            A two-way factor analysis for demographic characteristics and bowel pattern was done using 
Pearsons  Chi  Square  test,  Yates  corrected  Chi  Square  test  and  independent  student  t  test  wherever 
appropriate.  
                                                     RESULTS
A:  Normal bowel movement in healthy population:
A  total  of  841  individuals  were  contacted  for  the  normal  bowel  habit  questionnaire.  89 
individuals refused to participate.  Overall response rate was 89.4%.  There were 392 male and 360 
female individuals (M: F ratio: 1.1:1). 
Tab 3. Age, Sex distribution of general population 
Age group
                    Sex
Male (%)
 392
Female (%)
   360
15-29 (No=198) 105(26.7) 93(25.8)
30-44 (No=343) 174(44.3) 169(46.9)
45-59 (No=81) 44(22.2) 37(10.2)
>60  (No=130) 69(17.6) 61(16.9)
Table 3 summarizes the age, sex distribution of the population under study. Majority of the individuals 
were middle aged (46.9%)
Figure 7. Bowel frequency in general population
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           Figure shows the bowel frequency in men and women per day per week.  The average frequency 
was at least once a day.  The average frequency of bowel movement in the south Indian population of 
North Madras was 8.9 + 4.8 per week.  Stool frequencies between 3 times a week and 3 times a day 
was seen in majority of our respondents (95.8 %) (Fig.7). 75% reported a single bowel movement, 
followed by 2-3 times a day in 18%.  Twenty six persons (3.4%) had 3-5 stools/week, 16 persons i.e. 
2.1% had more than 3 stools per day and 10 individuals i.e. 1.3% had less than 3 per week. The median 
bowel movement was seven per week.  
Tab 4. Bowel frequency in our population: sex distribution
Sex                                           Bowel frequency
1/d (%) 2-3/d (%) >3/d (%) 3-5/wk (%) <3/wk (%)
Male 
(No=392)
295 (75.2) 72 (18.3) 9 (2.2) 13(3.3) 3 (< 1)
Female 
(No=360)
270 (75) 63(17.5) 7 (2.0) 13(3.6) 7(2.0)
The frequency of less than 3 per week was common amongst women. In the rest no difference 
in frequency was noted amongst the two genders. (Table   4)
Tab 5 Bowel frequencies in general population: age distribution
Age group                                           Bowel frequency
1/d 2-3/d >3/d 3-5/wk <3/wk
15-29  (No.)  % 
(No=198)
 48(74.7) 37(18.6) 4(2) 7(3.5) 2(1)
30-44 (%)
(No=343)
247(72) 67(19.5) 7(2) 14(3.9) 8(2.3)
45-59 (%)
(No=81)
 66(81.4) 10(12.3) 2(2.4) 3(3.7) None
>60(%)
(No=130)
104(80) 21(16.1) 3(2.3) 2(1.5) None
Table 5. shows the bowel frequency in different age groups. The frequency of at least once a day was 
common to all the age groups.  Bowel frequency of < 3 per week was common in middle age group.
B. Study of bowel movement in IBS: 
From amongst the healthy population there were 38 individuals who had features of IBS i.e. 
5.1%.  There were 26 men and 12 women patients.  These individuals had considered themselves as 
normal as far the bowel movements were concerned.  However, they had an altered bowel pattern in 
the form of altered frequency/form and with or without abdominal pain (Rome Criteria II).  In addition 
there were 144 cases of newly diagnosed IBS during the study period.  The combined results of 182 
cases of IBS will be highlighted from here on.
Tab 6. Age-Sex distribution in IBS
Age group Total Male Female
<20
21-40
41-60
>60
5
108
52
17
3
82
31
12
2
26
21
5
Total 182 128 54
Table 6 summarizes the age-sex distribution in IBS.  There were 128 men and 54 women (M:F 
ratio:2.4:1).  Majority of the patients were in the middle age group i.e., 3rd and 4th decades. The mean 
age for males was 37.7 +14.3 yrs and for females was 37 + 14.91yrs.
Tab 7. Other demographic characteristics in IBS
Variables Controls (%) 
714
IBS (%) 
182
p value
Smoking
Alcohol
Disturbed sleep
46(6.4)
30(4.2)
160(22.5)
19(10.4)
24(13.1)
55(30.2)
0.06
0.001
0.03
Table 7 shows the social  characteristics in IBS in comparison with the healthy controls. Smoking, 
alcoholism and disturbed sleep were higher in IBS patients, the latter two were statistically significant.
Tab 8.Duration of illness and age of patients
Age group 3-6 mo 6-12 mo 1-5 yrs 6-10 yrs >10yrs
<20 yrs
21-40 yrs
41-60 yrs
>60 yrs
2
9
3
1
2
34
14
4
1
42
18
5
0
17
9
2
0
6
8
5
Total 15(8.3) 54(29.8) 66(36.1) 28(15.2) 19(10.3)
Majority of the patients with IBS had symptoms between six months and five years (66%) before 
consulting a physician. 
Tab 9. Lower GI symptoms in IBS
Variable Total (%)
182
Male (%)
128
Female (%)
54
p value
Pain 76(41.7) 55(42.9) 21(38.8) NS
Frequency >3/rd 125 (68.6) 95(74) 30(55) 0.01
Frequency<3/wk 18(9.8) 8(6.2) 10(18.5) 0.01
Loose stools 127(69.7) 96(75) 31(57.4) 0.01
Hard stools 24(13.1) 12(9.3) 12(22.2) 0.02
Urgency 35(19.2) 21(16.4) 14(25.9) NS
Straining 54(29.6) 34(26.5) 20(37) NS
Incomplete evacuation 57(31.3) 39(30.4) 18(33.3.) NS
Mucus 46(25.2) 30(23.4) 16(29.6) NS
Bloat 54(29.6) 34(26.5) 20(37) 0.07
Table 9 shows the various lower GI symptoms in IBS.  Loose stool (69.7%) and increased frequency 
(68.6%) were the common symptoms followed by abdominal pain in 41.7%. Loose stool and increased 
frequency were common among males which were statistically significant. Hard stools (13.1%) and 
frequency of less than 3 per week (9.8%) was an uncommon presentation, but was statistically more 
common among females. 
Frequency >3/d
69%
Loose stool
70%
Frequency
<3/W10%
Hard stools
13%
Abd pain 42%
Urgency19%
Straining 30%
Incomplete
evac31%
Mucus 25%
Bloat 30%
Fig.8. Lower GI symptoms in IBS
The figure 8 shows the pictorial representation of various lower GI symptoms in IBS.  The loose stools 
(70%), increased frequency (69%) being the common presentation followed by Abdominal pain (42%)
Tab 10.  Age - sex wise distribution of bowel frequency in IBS  (M:F=128:54)
Age >3 / day <3 / day to >3 / wk <3 / wk
M F M F M F
< 20 yrs (5) 2 0 1 1 0 1
21-40 yrs (108) 63 19 13 8 3 2
41-60 yrs (52) 23 10 9 4 2 4
>60 yrs (17) 7 1 2 1 3 3
Table 10  shows the frequency of stools among the IBS patients with regard to age and sex. The 
frequency of less than 3 per day was common in the older age group (> 40 yrs) and in female sex. 
Increased frequency of stools was common among men of all age groups.
Tab 11.   Age and sex wise distribution of stool form in IBS (M:F=128:54)
Age Loose (Bristol 6,7) Normal (Bristol 3,4,5) Hard (Bristol1,2)
M F M F M F
< 20 yrs (No=5) 2 0 1 1 0 1
21-40yrs (No=108) 58 22 11 6 7 4
41-60yrs (No=52) 25 11 5 3 4 4
>60yrs (No=17) 8 1 3 1 1 3
Table 11 shows the consistency of stools among the IBS patients with regard to age and sex. 
Hard stool was common among females . Loose stools were more common among men.
Tab 12.Comparison between frequency vs. consistency of stool in IBS
Frequency of stool
Consistency of stool
Loose Normal Hard
>3/day 123 2 None
<3/day to >3/wk 4 27 8
<3/wk None 2 16
Table 12 shows the comparison between loose stools and frequency of stools. The frequency of 
stools correlated well with the consistency.  123 patients had frequency of more than 3 per day and the 
stools were loose. 16 patients who had a frequency of less than 3 per week passed hard stools.
Tab 13. Prevalence of IBS and its subtypes
IBS subtypes No (%) M(%) F(%) p value
Diarrhoea predominant (IBS-D)
Constipation predominant (IBS-C)
Non-specific (IBS-N)
139(76.4)
30(16.5)
13(7.1)
109(85)
14(11)
5(4)
30(55)
16(30)
8(15)
0.001
0.001
0.01
020
40
60
80
100
120
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Male
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                          Figure 9. IBS subtypes
On symptom analysis, there were 139 cases (76.4%) of Diarrhoea predominant IBS, 30 cases 
(16.5%)  of  Constipation  predominant  IBS  and  13  cases  (7.1%)  of  nonspecific    type  IBS.  The 
Diarrhoea predominant IBS was common among males and the constipation predominant and non 
specific types were common among females both were statistically significant.
Tab.14. Diarrhoea predominant IBS: Patient characteristics  (Total=109)
Table 14 shows the patient characteristics of Diarrhoea predominant IBS. The mean age of men and 
women were 37.6+15.6 and 41.6+12.1 years and this was statistically significant for women. There was 
no significant difference between either sex in any of the other demographic characteristics such as 
literacy status, sleep pattern and dyspepsia, genitourinary symptoms. There were no women smokers or 
alcoholics. 
Tab 15.Constipation predominant IBS : Patient characteristics (Total=30)
Table 15 shows the patient characteristics of Constipation predominant IBS. The mean age of men and 
women  were  35.4+9.8  and  39.3+7.2  years,  this  was  not  statistically  significant.   There  was  no 
significant difference between male and female in any of the other demographic characteristics such as 
literacy status, sleep pattern and dyspepsia, genitourinary symptoms. There were no women smokers or 
alcoholics. 
Tab 16. Comparison of bowel pattern in Diarrhoea predominant and Constipation  predominant –IBS.
Table 16 shows the other lower GI symptoms associated with IBS patients. Abdominal pain relieved 
with defecation and associated with change in form/frequency were equally present between diarrhoea 
and constipation predominant IBS. Incomplete evacuation, straining and bloating were significantly 
common  among  constipation  predominant  IBS.  Urgency  and  mucoid  stool  were  common  among 
diarrhoea predominant group though statistically not significant.
DISCUSSION
The prevalence of bowel symptoms has important implications for the allocation of resources 
and planning  of  medical  services.  These data  have  been  used  to  define  a  normal  range  of  bowel 
frequency  and  to  estimate  the  prevalence  of  IBS-type  symptoms  and  other  bowel  dysfunction 
symptoms  in  the  general  population  world  over.  Normal bowel  patterns  have  been  established  in 
western population. Similar studies in Indians are lacking. In a Spanish study by Roig Vila et al11,  the 
average number of stools was      7.1+   3.3 per week and in 62.4% of subjects the stool frequency was 
between the range of  5  and 8.   In  a  study by Abraham et  al  1 from Mumbai,  the median  bowel 
frequency in Indian adults was 2 per day. In an earlier study from Coimbatore,  Jayanthi et al 2 reported 
an average bowel  frequency of once a day amongst the college students,  and healthy attenders of 
hospital patients.  In the present study, consisting of a population from North Madras, Chennai, the 
median frequency of bowel movement was one per day similar to the other studies from Tamil Nadu. 
The mean frequency was 8.9  + 4.8 per week.   In a Spanish study by Roig Vila et al11, the bowel 
movements were less frequent in women than in men, nevertheless there were no differences with 
regard to age. Similarly in the present study except for constipation which was higher among females, 
there was no difference in bowel frequency with regard to the different age groups.  The present data 
cannot be extrapolated to the entire population of Tamil Nadu or the entire country.  Large population 
based studies from different parts of India, including urban and rural 
population will  ultimately give information of the actual  bowel pattern in  the Indian subcontinent. 
What is true of a normal bowel movement for Northern or other parts of India may not hold true for our 
population, largely because of the varying social and cultural, dietary differences etc.
 
IBS is  a  well  recognized clinical  entity in  the Western population.  Large population based 
epidemiological surveys in the United States 5 and the United Kingdom 3 have reported the prevalence 
to range from 17 to 22%, based on either Manning criteria or Rome criteria.  In Kwans et al  19  study 
from Hong Kong the prevalence of IBS in the general population was 6.6% and in another survey 
amongst medical students from Malaysia37 a high prevalence of 15.8% was reported. In the present 
study, using the same criteria, the prevalence of IBS amongst the healthy population was 5.1%. The 
results  are  consistent  with  the  findings  of  a  community-based  survey  in  Singapore,  wherein  the 
reported prevalence rate was of 2.3%. 14 A study from Thailand amongst thousand rural villagers and 
hotel  employees,  13 4.4% had symptoms of  IBS.  The south Asian prevalence  of  IBS amongst  the 
healthy population is similar to southern India.  The high prevalence in one of the Malaysian studies is 
probably the  bias  towards  the  affluent  class  of  medical  students,  a  highly stressed  group and  the 
likelihood of awareness of somatic symptoms. In previous studies on the prevalence of IBS the study 
group  consisted  of  a  small  population  and  therefore  does  not  truly  reflect  the  prevalence  in  the 
community.  Despite this, it appears that  the IBS prevalence in southern India is similar to the other 
south Asian countries.  
The community prevalence of IBS appears to be definitely lower in the East than the West. The 
reason  for  this  difference  is  unknown and  requires  further  study.  The  dietary  factors  such  as  an 
increased intake of fibers and low fat content in the food may be contributory.
Although  IBS  affects  both  genders,  it  is  largely  a  problem  amongst  women  in  the  western  population. 
Epidemiological data suggests that the female: male ratio of IBS sufferers in the community is 2-3:1,3,7 although estimates 
differ depending on the practice setting from which such assessments are generated. Generally, however, two thirds of IBS 
sufferers in North America who seek medical care are women.5 In the present study, IBS was more common among men in 
the ratio of 2.4:1 with a male predominance in contradiction to west.  An earlier study in 1996,  47 which looked into the 
bowel pattern of  IBS patients, the males were predominantly affected. The differences in health care-seeking behavior, 
awareness and education status among male, may partly account for this predominance. 
IBS commonly involves the middle age group. Average age group of IBS individuals in the 
study population was 37.7 + 15.2 years, similar to the report from Hong Kong by Kwan et al 36 of 39.8 
years. In the present study there was no significant difference among subjects with different education 
levels.  Kwan et al36 found no significant difference among subjects with different education levels.
Smoking and alcohol consumption was present only amongst men in the IBS group and this 
was statistically higher amongst the IBS patients. In the Malaysian study45 there was no differences in 
the alcohol intake, smoking habit, chilli consumption or fibre intake between IBS and non-IBS groups. 
Sleep pattern disturbances was higher in IBS population in the present study. A similar observation was 
made by Tan et al  45.  He reported a high prevalence self reported psychological and psychosomatic 
symptoms, namely anxiety, depression, and insomnia.
Tutega et al 9 found a striking overlap between IBS and functional dyspepsia: 
70% of individuals with IBS also had functional dyspepsia, whereas 43% of subjects with dyspepsia 
also   had IBS.  In   our   study the prevalence   of   dyspepsia   in    IBS was 36.8%, which    was 
significantly  higher  than  in the general population.   IBS patients have the 
dysmotility  “abnormalities” in 25%–75% as evidenced by a delayed emptying especially 
for  solids.   One–fourth   of  patients  with  IBS  and  co-morbid  dyspepsia  had  electrogastrogram 
abnormality,  but  was  present  in  only  8%  of  IBS  without  dyspepsia, 35 indicating  that  motility 
abnormalities are not uncommon in IBS population. 
Symptom subgroups based on predominant bowel habit showed the majority of individuals with 
IBS had diarrhoea  predominant  subtype  (76.4%) with  predilection  for  male  sex.  The  constipation 
predominant group was 16.5% and the non-specific sub type in 7.1%. This is in contradiction to the 
previous studies. In the Malaysian study 45 and a study by Mearin et al,46 the constipation predominant 
IBS was the predominant subtype .  Constipation predominant IBS was more common in females in the 
present study. In Kwans19 study interestingly the nonspecific IBS subtype was predominant with 56% 
followed by diarrhoea predominant i.e. 27% and constipation predominant with 17%.            The 
nonspecific form was not prominent in the present study, since most patients had either diarrhoeic or 
constipated form and very few had a combination of both.  
The  prevalence  of  bowel  symptoms  arranged  in  descending  order  was:  Loose  stools 
(69.7%),increased  frequency  of  stools  (68.6%),  abdominal  pain  (41.7%),  incomplete  evacuation 
(31.3%), bloating and straining (29.6%)  mucus in stools (25.2%) urgency (19.2%), and hard stools 
(13.1%),  decreased  frequency  of  stools(9.8%). This  study  shows  that  loose  stool  with  increased 
frequency was the common symptom in IBS compared with the pain predominant type in the west. 
This was similar to the previous study from Chennai47 where the abdominal pain was uncommon (35%) 
and loose stool the predominant symptom (75%). There was significant difference between male and 
female with loose stools and increased frequency were common among males and hard stools and 
frequency <3/week were  common in females that  is statistically significant.   Similar data are not 
available from rest of our country. 
Pain  a  dominant  feature  characterizing  IBS,  and a  significant  factor  in  Rome’s  criteria  for 
diagnosing IBS, was distinctly rare in the present study (41.7%, n=76).  On applying  Rome  II criteria 
for diagnosis which has abdominal pain as the major criteria only 42 % of the patients in the present 
series satisfied the criteria.  Also it was not a dominant factor for diarrhoea or constipation predominant 
IBS, suggesting that pain may not   necessarily    be    an  important  factor  for  inclusion  or  exclusion 
of a case as IBS.  
Whether threshold of pain i.e. visceral hyperalgesia is set at higher levels for south Indians needs to be 
studied and results validated or is it that our patients are actually suffering from functional diarrhoea 
and not ‘true’ IBS ? Similar observations have been made by other gastroenterologists from other parts 
of India  (Jayanthi et al, personal communication:  Core Meet of ISG, Neemrana, 2005).  Validity of 
Romes Criteria II needs to be validated for our patients in the near future.  
SUMMARY
A.Bowel pattern in general population:
a. The average bowel frequency was 8.9 + 4.8 per week with 95.8% of  patients
reporting a stool frequency between 3 and 21 times per week. 
b. There was no difference with regard to age and sex in terms of bowel frequency and the form of 
stool except for those passing less than 3 per week.
c. Bowel movement of less than 3 per week was common amongst women
d.   The prevalence of IBS in general population was 5.1% 
B. Bowel pattern in IBS
a. IBS was more common among men in the ratio of 2.4:1.
b. The mean age of IBS patients was 39.3+12.2 years; majority of the patients were in the 3rd and 
4th decades of life. 
c. The duration of symptoms varied from 6 months to 5 years in 66%.  Very few had an illness 
less than 6 months  (8%).
d. Alcohol, smoking and disturbed sleep pattern was distinctly common amongst IBS as compared 
to the general population
e. Loose stool (69.7%) and increased frequency (68.6%) were the common symptoms followed by abdominal pain in 
41.7%. Loose stool and increased frequency  were common amongst men which was statistically significant. Hard 
stools  (13.1%) and  frequency of  <  3 per  week  (9.8%) was  an  uncommon presentation,  this  was  statistically 
significant among females. 
f. Frequency and consistency of stools correlated in the majority. Higher the frequency more loose 
was the stool.  
g. Subtypes:  
i. Diarrhoea predominant type  (139): 76.4%
ii. Constipation predominant (30):  16.5%
iii. Non specific /combination type (13):  7.1%
The Diarrhoea predominant type  was common amongst men and the constipation 
predominant type was common amongst women both being statistically significant.
h. Diarrhoea predominant IBS:  
i. Age of presentation was higher among women in comparison to men: (females: 41.6 
+ 12.1 yrs vs. males:  37.6 + 15.6 yrs)
ii. No significant differences among other lower GI symptoms, dyspepsia, genitourinary 
symptoms or in their demographic characteristics in either gender
i.    Constipation – predominant IBS:
No significant difference in other lower GI symptoms, dyspepsia, genitourinary 
symptoms or in their demographic characteristics in either gender
j. Comparing the associated lower GI symptoms in the two major subtypes
IBS-D and  IBS-C
i. Incomplete evacuation, bloating and straining was significantly higher in IBS-C
ii. Urgency and passage of mucus was common in IBS-D, though not statistically 
significant.
CONCLUSION
Large population based studies are likely to provide a definite information 
on the normal bowel habit of southern Indian population of Tamil Nadu.  
There may be a need to redefine the existing Rome II criteria for the 
southern Indian population of Tamil Nadu, since pain is not a dominant feature of IBS in this 
population.
The recommendations  for diagnosis of IBS amongst the southern Indian 
population of Tamil Nadu requires  the incorporation of  the following variables.
a. Alteration of bowel pattern in terms of frequency / consistency 
b. Duration of illness of more than or equal to 6 months
c. Pain should not be a major criteria for diagnosing IBS, rather it should be only a supportive 
feature
d. Criteria for subtypes: 
i. Diarrhoea predominant-IBS:  Stool frequency > 3 per day, loose stool, with or 
without abdominal pain, presence of urgency and mucus in stool
ii. Constipation predominant -IBS: stool frequency of less than 3 per week, hard 
stool, associated with abdominal bloat, straining and incomplete evacuation 
during the passage of stool 
The proposed revised criteria needs validation in future prospective studies. 
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Annexure 1
Proforma I: Bowel habits in healthy Southern Indian Individuals:
S.No.   
Age:
Sex :
Occupation:
Educational qualification: Uneducated/ Primary/ Secondary/ College
Smoker: Yes/ No
Alcoholic: Yes/ No 
What time did you sleep last night:
Did you have a Good/ disturbed sleep
As regards to your bowel movement
Do you pass motion every day? Yes/No
How many times do you pass on an average/ day/ week:
Consistency:  Hard/ formed/ loose
Do you have abdominal discomfort / pain: Yes / No
If yes does the pain get relieved after defecation: Yes/ No
Pain associated with change in consistency: Yes/ No
Pain associated with change in frequency : Yes/ No
Do you want to pass but cannot pass :  Yes / No
Do you pass mucus in stools?: Yes/No
Do you strain to pass stool : Yes / No
Do you have urgency : Yes / No
Do you regard yourself as  : Normal/ Diarrhoea/ Constipation
If IBS:  further evaluation as per Proforma II
                                                                          
                                                                       
      Annexure 2
                                
  Proforma II:  IBS PATIENT DATA
Name:
Age   :
Sex: Male/ Female
Address:
Occupation: 
Education: Uneducated/ Primary/ Secondary/ College
Smoking : Yes/No
Alcohol: Yes/No
Sleep Disturbance :Yes/No
SYMPTOMS
How long are you suffering from your symptoms?
How many times do you pass on an average: 
                                  <3 per week / 3 per day to 3 per week/ >3per day
What is the consistency of stools? Hard/ formed/ loose
Do you have abdominal discomfort / pain: Yes / No
• If yes does the pain get relieved after defecation : Yes/ No
• Onset of pain associated with change in consistency : Yes/ No
• Onset of pain associated with change in frequency : Yes/ No
Incomplete evacuation? Yes/ No
Mucus with stools? Yes/ No 
Unusual straining? Yes/ No
Urgency? Yes/ No
Abdominal bloat? Yes/ No
Upper abdominal pain and burning (discomfort)? Yes/ No
Burning in the chest? Yes/ No
Chest pain? Yes/ No
Urinary difficulty? Yes/ No
Burning during passing urine? Yes/ No
Do you have any source of tension in family/
present workplace or elsewhere? (Stress) Yes/ No
Bleeding during passing stool? Yes/ No
Do you have diarrhoea after going to bed at night?Yes/ No
History of weight loss/ Reduced Appetite? Yes/ No
Investigations
Hb%:      g/dl
TC   :      /mm3
DC   :
Blood sugar:      mg/dl
(F / PP /R )
Stool microscopy :
         Occult blood : +ve/ -ve
Blood sugar:
Blood urea/S. Creatinine
Thyroid function tests:  T3, T4, TSH
Ultrasound -
Barium meal -
Barium enema-
UGI Endoscopy (specify)
Duodenal Biopsy -
Colonosocpy (specify) -
Any other (specify)
 
